Biocon Biologics
Anjula Katoch is a Senior Scientist at Biocon Biologics, with previous experience as a Senior Scientific Officer and Senior Executive at Panacea Biotec. Prior to that, Anjula worked as a Research Associate at Exelex biopolymers pvt. ltd and CSIR-IMTECH. Anjula's expertise lies in isolation, screening, and identification of exopolysaccharide (EPS) producing strains and scale-up of fermentation processes. Anjula also has experience in microbiology techniques and molecular techniques from their time at Orbit biotech pvt. ltd. In addition, Anjula has worked as a Biology Tutor and holds a Master's degree in Biotechnology from Panjab University.
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics